AireHealth and LucidAct Health Partner in Connecting In-Home Chronic Respiratory Patients with their Provider Care Teams
LucidAct Health, the leading care coordination platform for virtual care, is pleased to announce integration of their LucidAct Provider Portal with AireHealth’s digital health solution to support remote management of chronic obstructive pulmonary disease (COPD) and other chronic respiratory conditions.
As of January 2021, the Centers for Medicare & Medicaid Services (CMS) has approved over 56 hospitals for its hospital-care-at-home model, which studies have shown to improve outcomes and lower cost, with the added benefit of patients being able to recover in the comfort of their homes. The CMS has stated that with proper monitoring, more than 60 conditions including congestive heart failure (CHF), COPD, and pneumonia can be treated in home settings.
Annually, delayed diagnosis and treatment, poor adherence, and preventable hospitalization contribute to over $130B of unnecessary costs. Further, respiratory conditions such as Asthma, COPD, respiratory viruses, pneumonia, and cystic fibrosis account for 49.2 deaths per 100,000.
The AireHealth digital health solution includes an FDA-cleared connected portable nebulizer and diary companion app with the following features:
Lightweight and quiet portable design to empower people with COPD and other chronic respiratory conditions to stay connected with care teams and live their life on-the-go
MyAireHealth diary companion app enables care teams to monitor data for treatment adherence and actionable symptoms to proactively identify and triage their high-risk respiratory patients
Bluetooth wireless data transmission to LucidAct, which in turn integrates with the provider’s EMR to support clinical decision-making, helping to reduce unnecessary hospital readmissions
The AireHealth-LucidAct chronic respiratory RPM (Remote Patient Monitoring) solution combines the AireHealth portable nebulizer and MyAireHealth companion app with the LucidAct Provider Portal to support the following use cases:
Enhancing a healthcare provider’s new or existing chronic respiratory management program with remote monitoring to help close gaps in care
Monitoring patients who are vulnerable to COVID-19, such as people with COPD and chronic asthma, for COVID-19 symptoms in their homes
Adding remote monitoring capability to a health system’s post-acute and virtual care programs to monitor nebulizer medication adherence and proactively triage high-risk respiratory patients
Implementing chronic care management (CCM) program for COPD and Asthma patients in rural settings
LucidAct Health’s care coordination platform relays AireHealth’s in-home treatment data to the providers’’ EMR system. Beyond data transmission, LucidAct enables order automation, smart SMS for patient engagement, advanced data analytics and notification of anomalies, no-code triage workflow customization, and insurance billing automation.
About LucidAct Health (www.lucidact.com) :
LucidAct Health is the next generation provider portal for virtual care delivery. The easiest way to connect hundreds of in-home medical devices via APIs, mobilizing LucidAct’s network of nurses, care coordinators, and health coaches via workflow automation to delivery faster care like never before.
Contact firstname.lastname@example.org for more information about how LucidAct provider portal can power up your virtual care delivery faster and most cost effectively.
About AireHealth (www.aire.health)
AireHealth is an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking and early detection of respiratory conditions. With strong IP and clinically validated products in our pipeline, AireHealth enables more proactive care and early interventions to improve outcomes and reduce costs. For more information.
Contact email@example.com for more information about partnering opportunities and to discuss how the AireHealth digital health solution can improve medication adherence and engagement with your COPD and other chronic respiratory patients.
For more information on the Acute Hospital Care at Home program, please visit the CMS web page: https://www.cms.gov/newsroom/press-releases/cms-announces-comprehensive-strategy-enhance-hospital-capacity-amid-covid-19-surge
AIREHEALTH BREATHES EASIER WITH FDA 510(k) CLEARANCE OF CONNECTED NEBULIZER
By: Annette Boyle - BioWorld MedTech
Airehealth Inc.'s management took a deep breath on hearing that the company's Vitalmed nebulizer received U.S. FDA 510(k) clearance after waiting nearly 11 months. The portable, electronic, vibrating mesh nebulizer will connect to the Orlando, Fla.-based company's diary companion app early next year as part of an integrated suite of products designed to help individuals with chronic respiratory issues track symptoms and better manage their care.
“Consumers facing chronic respiratory issues require care, resources and tools that integrate with their day-to-day lives, which is why the development of a connected platform to comprehensively address their needs is so vital,” said Rebecca Shanahan, Airehealth’s interim CEO. “Airehealth is pleased to have received 510(k) clearance of our connected nebulizer from the FDA, which will support the creation of an overall ecosystem of connected solutions to treat patients with respiratory conditions.”
TRANSFORMING THE HEALTHCARE INDUSTRY WITH PROJECT HEALTHCARE 2020
August 5, 2020
By: Nashville Entrepreneur Center
This week, we are honored to introduce you to the 31 teams joining Project Healthcare 2020, Nashville’s top healthcare accelerator-level program. These amazing teams from around the country were chosen from a highly competitive applicant pool to receive resources and support from the best-of-the-best in Nashville's healthcare ecosystem, including The Nashville Health Care Council, Amsurg, Carefluence, LaunchTN, and Burr & Foreman LLP.
“Through listening closely to the business community, investors and entrepreneurs, it became clear that we all need to work closely to help Nashville be the best place to start and grow a business,” said CEO Jane Allen. “We were amazed with the quality companies and entrepreneurs which made this a highly competitive process.”
THESE FOUNDERS ARE USING A SMART NEBULIZERS TO HELP 100 MILLION PEOPLE BATTLING RESPIRATORY ILLNESS
August 4, 2020
By: StartUp Health
AireHealth CEO & Founder Stacie Ruth and Head of Innovation Nirinjan Yee have built a game-changing solution for at-home respiratory care, providing precise detection and tracking of lung disease amid COVID-19 and beyond.
When COVID-19 hit, AireHealth looked for ways to accelerate through the economic downturn through a partnership. In June, AireHealth acquired BreathResearch in a merger that was designed to help build the industry’s first virtual care platform for respiratory illness. The partnership between AireHealth and BreathResearch is enabling the company to save the lungs and improve the quality of life for those with respiratory conditions on a larger scale.READ AND WATCH MORE
TO MITIGATE AND TRACK COVID-19, ENTREPRENEURS PUSH TO DEVELOP TOOLS
July 15, 2020
By: David M. Ewalt - The Wall Street Journal
If necessity is the mother of invention, a pandemic is a powerful fertility drug. That is evident in the current coronavirus crisis, which has inspired researchers and entrepreneurs to accelerate the development of tools and technologies that might be useful in containing the virus or mitigating its effects.
BreathResearch of Walnut Creek, Calif., is developing a system that would allow doctors to detect and track the progression of respiratory disease by recording and analyzing the sound of a patient’s breathing.
In early June, BreathResearch agreed to merge with AireHealth Inc., a health company focused on respiratory diseases.
A VIRTUAL CARE PLATFORM FOR RESPIRATORY ILLNESS:
INTERVIEW WITH STACIE RUTH, CEO OF AIREHEALTH
July 2, 2020
By: Conn Hastings -
Recently, AireHealth announced a merger with BreathResearch, a respiratory healthcare company based in Silicon Valley that specializes in detection and monitoring of respiratory diseases. The company has developed a portable spirometer that can be used to measure lung health. The technology involves analyzing breathing sounds and lung flow volumes using AI and machine learning to recognize changes in a respiratory condition.
This technology will be merged with that of AireHealth to form VitalBreath, a virtual care platform for respiratory illness. The system encompasses disease monitoring, including a lung health score based on 35 different biomarkers, drug delivery, and patient apps that aim to increase patient engagement and medication adherence.
Medgadget had the opportunity to talk to Stacie Ruth, AireHealth Co-Founder and CEO, about this technology.
AIREHEALTH ACQUIRES BREATHRESEARCH TO FLESH OUT IT'S DIGITAL RESPIRATORY HEALTH PLATFORM
June 8, 2020
By: Dave Muorio - MobiHealthNews
AireHealth, maker of an FDA-cleared portable nebulizer that pairs with a smartphone app for remote monitoring, announced Friday the acquisition of fellow respiratory health company BreathResearch. Financial terms of the deal were not disclosed.
AireHealth already looks to set itself apart with patient-facing digital features and adherence tracking. The new combined offering, VitalBreath powered by BreathResearch, appears to be strengthening the virtual care platform's capabilities so that it can support early detection of respiratory decline.
VitalBreath powered by BreathResearch will support a patient app, adherence tracking and data-analysis capabilities focused on detecting early respiratory decline.READ MORE
AIREHEALTH MAKES HEALTHLINE'S BEST ASTHMA BLOGS OF 2020
May 15, 2020
Each year, Healthline
looks for asthma-focused online resources that offer accurate medical information, insight, and a sense of community to those who need it.
AireHealth is proud to be selected as one of Healthline's Best Asthma Blogs of 2020. Each blog was selected based on the quality of content, the consistency in posts, and engagement with its community.
ORLANDO COMPANY'S PORTABLE NEBULIZER MAY ENHANCE COVID TREATMENT
April 3, 2020
By: Justin Braun - Orlando Economic Partnership
Orlando startup AireHealth, based in the University of Central Florida (UCF) Research Park Incubator, has a portable nebulizer that uses a proprietary delivery mechanism to significantly enhance the delivery of drugs for lung related treatments and therapies.
That’s why on March 30, AireHealth announced it was eager to help support the national effort to stem the impacts of the novel Coronavirus, putting out a call for collaborators to help apply the firm’s technology to help coronavirus patients.
HOW THESE 4 LOCAL TECH FIRMS & MANUFACTURERS ARE HELPING THE STRESSED HEALTH CARE SYSTEM
April 3, 2020
By: Alex Soderstrom - Orlando Business Journal
UP CLOSE WITH STACIE RUTH
By: Meaghan Branham - i4 Business Magazine
As the daughter of two business owners, AireHealth CEO and Co-Founder Stacie Ruth knew she wanted to make her mark on the world of business in her own way. Once she found a passion for health care, she knew the business side of the industry would be her calling and soon zeroed in on the production and commercialization of medical products. With the creation of the AireHealth connected nebulizer and Asthma App, Ruth hopes to do the same with her own product. Here, she discusses how and why she founded AireHealth and how tech changes the landscape for sustainable health care.
AIREHEALTH CHOSEN FOR INAUGURAL GUIDEWELL HEALTH TECH ACCELERATOR
June 20, 2019
By: The University of Central Florida
AireHealth, the recent winner of Rise of the Rest, has been chosen to participate in a new program from GuideWell Innovation
designed to help women-founded health care technology companies accelerate their growth.
The firm was one of just five companies from the entire Southeast U.S. and the only one based in Orlando...
GUIDEWELL INNOVATION SELECTS SIZE WOMEN-FUNDED HEALTH TECH COMPANIES FOR SUMMER SCALE-UP ACCELERATOR COHORT
June 17, 2019
By: Florida Trend
“The GuideWell Scale-Up Accelerator is an eight-week technology accelerator program focused on “Scale-Up” health technology or medical device companies. This cohort is dedicated to companies with women founders that are headquartered in the southeastern U.S.”
RISE OF THE REST: FOSTERING GROWTH REVOLUTION FOR STARTUPS
By: Justin Braun - i4 Business Magazine
"Medical technology developed right here in Central Florida is about to disrupt the billion-dollar respiratory care device market. Startup company AireHealth has created a connected nebulizer with the potential to provide patient care and treatment…"
3 LOCAL WOMEN'S BIOTECH FIRMS CHOSEN FOR 2 NEW ACCELERATOR PROGRAMS
July 1, 2019
By: Malak Saleh - Orlando Business Journal
Three Orlando firms were chosen among 11 from across the Southeast to participate in GuideWell Innovation
's two new business accelerator programs.